Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated With High-Grade Glioma Publisher



Heidari M1 ; Shokrani P1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Medical Signals and Sensors Published:2024


Abstract

Background: Glioma is one of the most drug and radiation-resistant tumors. Gliomas suffer from inter- and intratumor heterogeneity which makes the outcome of similar treatment protocols vary from patient to patient. This article is aimed to overview the potential imaging markers for individual diagnosis, prognosis, and treatment response prediction in malignant glioma. Furthermore, the correlation between imaging findings and biological and clinical information of glioma patients is reviewed. Materials and Methods: The search strategy in this study is to select related studies from scientific websites such as PubMed, Scopus, Google Scholar, and Web of Science published until 2022. It comprised a combination of keywords such as Biomarkers, Diagnosis, Prognosis, Imaging techniques, and malignant glioma, according to Medical Subject Headings. Results: Some imaging parameters that are effective in glioma management include: ADC, FA, K trans, regional cerebral blood volume (rCBV), cerebral blood flow (CBF), v e, Cho/NAA and lactate/lipid ratios, intratumoral uptake of 18 F-FET (for diagnostic application), RD, ADC, v e, v p, K trans, CBF T1, rCBV, tumor blood flow, Cho/NAA, lactate/lipid, MI/Cho, uptakes of 18 F-FET, 11 C-MET, and 18 F-FLT (for prognostic and predictive application). Cerebral blood volume and K trans are related to molecular markers such as vascular endothelial growth factor (VEGF). Preoperative ADC min value of GBM tumors is associated with O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status. 2-hydroxyglutarate metabolite and dynamic 18 F-FDOPA positron emission tomography uptake are related to isocitrate dehydrogenase (IDH) mutations. Conclusion: Parameters including ADC, RD, FA, rCBV, K trans, v p, and uptake of 18 F-FET are useful for diagnosis, prognosis, and treatment response prediction in glioma. A significant correlation between molecular markers such as VEGF, MGMT, and IDH mutations with some diffusion and perfusion imaging parameters has been identified. © 2024 Journal of Medical Signals & Sensors.
Related Docs
View other Related Docs
1. Using of Laplacian Re-Decomposition Image Fusion Algorithm for Glioma Grading With Swi, Adc, and Flair Images, Polish Journal of Medical Physics and Engineering (2021)
2. Joint Application of Biochemical Markers and Imaging Techniques in the Accurate and Early Detection of Glioblastoma, Pathology Research and Practice (2021)
3. Post-Chemo-Radiotherapy Response and Pseudo-Progression Evaluation on Glioma Cell Types by Multi-Parametric Magnetic Resonance Imaging: A Prospective Study, BMC Medical Imaging (2023)
4. Improvement Grading Brain Glioma Using T2 Relaxation Times and Susceptibility-Weighted Images in Mri, Informatics in Medicine Unlocked (2023)
5. Prospective Prediction of Treatment Response in High-Grade Glioma Patients Using Pretreatment Tumor Adc Value and Mir-222 and Mir-205 Expression Levels in Plasma, Journal of Biomedical Physics and Engineering (2024)
6. Multiparametric Study for Glioma Grading With Flair, Adc Map, Eadc Map, T1 Map, and Swi Images, Magnetic Resonance Imaging (2023)
7. Investigation and Comparison of Coplanar Versus Noncoplanar Intensity-Modulated Radiation Therapy (Imrt) Techniques in Glioblastoma Multiforme Tumors, Journal of Isfahan Medical School (2018)
8. Performance Comparison of Different Medical Image Fusion Algorithms for Clinical Glioma Grade Classification With Advanced Magnetic Resonance Imaging (Mri), Scientific Reports (2023)
Experts (# of related papers)
View all Related Experts
Mohammad Bagher Tavakoli (8)
Parvin Mahzouni (6)
Other Related Docs
9. Brain-Derived Neurotrophic Factor (Bdnf) As a Potential Biomarker in Brain Glioma: A Systematic Review and Meta-Analysis, Brain and Behavior (2025)
10. A Systematic Review of Extracellular Vesicles As Non-Invasive Biomarkers in Glioma Diagnosis, Prognosis, and Treatment Response Monitoring, Molecular Biology Reports (2021)
11. A Review of Glioblastoma Tumors With Primitive Neuronal Component and a Case Report of a Patient With This Uncommon Tumor at a Rare Location, Clinical Case Reports (2020)
12. Magnetic Resonance Spectroscopic Analysis in Brain Tumors, Medical Imaging Methods: Recent Trends (2019)
13. Evaluation of Endoglin As an Angiogenesis Marker in Glioblastoma, Iranian Journal of Pathology (2015)
14. Optimization of Ct Slice Thickness in 3D-Crt and Imrt Planning of Low Grade Glioma, International Journal of Radiation Research (2021)
15. Glioma Segmentation With Dwi Weighted Images, Conventional Anatomical Images, and Post-Contrast Enhancement Magnetic Resonance Imaging Images by U-Net, Physical and Engineering Sciences in Medicine (2022)
16. Measurement of Apparent Diffusion Coefficient (Adc) Values of Ependymoma and Medulloblastoma Tumors: A Patient-Based Study, Journal of Biomedical Physics and Engineering (2021)
17. Electrochemical Biosensors for Early Diagnosis of Glioblastoma, Clinica Chimica Acta (2024)
18. Ultra-Small But Ultra-Effective: Folic Acid-Targeted Gold Nanoclusters for Enhancement of Intracranial Glioma Tumors' Radiation Therapy Efficacy, Nanomedicine: Nanotechnology, Biology, and Medicine (2019)
19. Differentiation Between Reactive Gliosis and Astrocytomas by Mib-1/Ki67 Immunostaining, Journal of Research in Medical Sciences (2007)
20. Determining the Relationship Between Microvessel Density and Different Grades of Astrocytoma Based on Immunohistochemistry for Factor Viii-Related Antigen (Von Willebrand Factor) Expression in Tumor Microvessels, Indian Journal of Pathology and Microbiology (2010)
21. Automatic Segmentation of Glioma Tumors From Brats 2018 Challenge Dataset Using a 2D U-Net Network, Tehran University Medical Journal (2022)
22. Early Detection of Radiation-Induced Injury and Prediction of Cognitive Deficit by Mrs Metabolites in Radiotherapy of Low-Grade Glioma, BioMed Research International (2021)
23. Glioblastoma Multiforme: Insights Into Pathogenesis, Key Signaling Pathways, and Therapeutic Strategies, Molecular Cancer (2025)
24. Advancing Oncology Through Imaging: Evaluating Fdg-Pet's Role in Cancer Diagnosis and Staging, Frontiers in Biomedical Technologies (2024)
25. The Apparent Diffusion Coefficient Changes After Radiation Therapy in Patients With Astrocytoma Cancer and Its Relationship With Tumor Volume-Dose, Journal of Isfahan Medical School (2022)
26. Evaluation of O6-Methylguanine-Dna Methyltransferase Enzyme Expression Effect on Survival of Patients With Grade 4 Brain Astrocytoma, Journal of Research in Medical Sciences (2014)
27. Investigation of Serum Levels and Tissue Expression of Two Genes Igfbp-2 and Igfbp-3 Act As Potential Biomarker for Predicting the Progression and Survival in Patients With Glioblastoma Multiforme, Journal of the Neurological Sciences (2016)
28. Radiomic Feature Reproducibility: The Impact of Inter-Scanner and Inter-Modality Variations, Iranian Journal of Medical Physics (2021)
29. Determining the Optimum Tumor Control Probability Model in Radiotherapy of Glioblastoma Multiforme Using Magnetic Resonance Imaging Data Pre- and Post- Radiation Therapy, Journal of Research in Medical Sciences (2022)
30. Classification and Staging of Brain Glioma Tumors Using Magnetic Resonance Imaging and Machine Learning Algorithms, Journal of Isfahan Medical School (2022)
31. Auto-Segmentation and Classification of Glioma Tumors With the Goals of Treatment Response Assessment Using Deep Learning Based on Magnetic Resonance Imaging, Neuroinformatics (2023)
32. Prediction of Normal Tissue Complication Probability (Ntcp) After Radiation Therapy Using Imaging and Molecular Biomarkers and Multivariate Modelling, Journal of Molecular Neuroscience (2023)
33. Targeting Glioma Cells With Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives, Mini-Reviews in Medicinal Chemistry (2023)
34. Prostate-Specific Membrane Antigen Expression in Neovasculature of Glioblastoma Multiforme, Advanced Biomedical Research (2019)
35. An Immunohistochemical Study of Cyclin D1 Expression in Astrocytic Tumors and Its Correlation With Tumor Grade, Iranian Journal of Pathology (2019)
36. Hippocampal Sparing in Dose-Painting Radiotherapy in High-Grade Glioma, Journal of Isfahan Medical School (2017)
37. Simultaneous Comparison of Image Quality and Radiation-Induced Cancer Risk in Brain Ct Scans Among Different Scanners, Journal of Isfahan Medical School (2024)
38. Diffusion‑Weighted Mri Monitoring of Embolic Brain Stroke for Covid‑19 Patients, Advanced Biomedical Research (2023)
39. Evaluation of Image Quality, Organ Doses, Effective Dose, and Cancer Risk From Pediatric Brain Ct Scans, European Journal of Radiology (2023)
40. Diagnostic and Prognostic Value of Stem Cell Factor Plasma Level in Glioblastoma Multiforme Patients, Cancer Medicine (2021)
41. Preliminary Study of Multiple B-Value Diffusion-Weighted Images and T1 Post Enhancement Magnetic Resonance Imaging Images Fusion With Laplacian Re-Decomposition (Lrd) Medical Fusion Algorithm for Glioma Grading, European Journal of Radiology Open (2021)
42. Diffusion-Weighted Mr Image Analysis Based on Gamma Distribution Model for Differentiating Benign and Malignant Brain Tumors, Medicine (United States) (2024)
43. Evaluation of the 3-Year Survival Rate in Patients With All Kinds of Glioma Tumors in Alzahra Hospital, Isfahan, Iran, 2001-2010, Journal of Isfahan Medical School (2016)
44. Research Paper: Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution, Iran, 2001-2010, Iranian Journal of Neurosurgery (2020)